Discontinued — last reported Q2 '22
Ameren Short-Term Borrowings increased by 83.2% to $1.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.9%, from $1.25B to $1.18B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 5.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $431.00M | $553.00M | $545.00M | $1.10B | $1.02B | $1.22B | $1.07B | $1.25B | $1.33B | $1.34B | $536.00M | $868.00M | $691.00M | $1.54B | $1.14B | $1.25B | $1.14B | $903.00M | $643.00M | $1.18B |
| QoQ Change | — | +28.3% | -1.4% | +102.0% | -7.3% | +19.6% | -12.4% | +16.6% | +6.5% | +0.8% | -60.0% | +61.9% | -20.4% | +122.7% | -25.7% | +9.5% | -8.9% | -20.9% | -28.8% | +83.2% |
| YoY Change | — | — | — | — | +136.9% | +120.8% | +96.3% | +13.4% | +30.2% | +9.7% | -49.9% | -30.4% | -48.0% | +14.9% | +113.2% | +44.2% | +65.1% | -41.3% | -43.7% | -5.9% |